Welcome!

Are you concerned about or even facing Prostate Cancer?

Do you have questions such as  “what do I do now”, “how to cope” and “why me”?

Hopefully, this website can help. You won’t find all of the answers here, but what you will find is the experience of one man, Dr. Bjarne Gabrielsen, who has faced, and continues to face, this challenge since 1995.

Within the pages of this site, are many current developments in the diagnosis and treatment of prostate cancer, medical resources and updates, spiritual and temporal experiences gained and lessons learned by the writer over a period of nearly twenty years.

Please read on to learn a little more…here is a great place to start.

NEW!!! If you are a man over 40, an initial overview of prostate cancer screening, detection and related issues can be found in the December 28th, 2015 and the March 12th, 2016 posts.

For additional “beginner” information on prostate cancer, see the May 17, 2015 post.  For “how to communicate with God”, see the February 17th, 2016 post.

You can generate an automatic e mail subscription to these blogs as they are posted by providing your e mail address on the lower right hand  corner of this home page. Your e mail comments are also always welcome.

IMPORTANT INFORMATION ON SPECIFIC BLOG POSTS;  The latest posts were written April 22nd, April 20th, March 24th, March 12th, March 7th, Feb. 22nd (God’s promises). Do you need to hear from God?  See Feb. 17th, 2016. A blog posted Feb. 16th described Us TOO, a general prostate cancer resource. Information on two new drugs (Topsalysin and Fexapotide triflutate) currently in Phase 2 clinical trials was written in the updated January 3rd, 2012 blog listing prostate cancer drugs either approved or under development. Other recent 2016 posts are February 3rd, February 2nd. There is a special video dated April 30th, 2015.  New guidelines for the treatment of hormone-resistant prostate cancers were posted on September 26th, 2014.  An interesting clinical trial was posted on July 11th, 2012 for men with low-volume prostate cancer. For updated clinical trials information, see the Medical Resources section on this website.